Literature DB >> 12563527

Gender-related differences in the effects of nitric oxide donors on neuroleptic-induced catalepsy in mice.

J G P Pires1, P G Costa, F P Saraiva, V Bonikovski, H A Futuro Neto.   

Abstract

It has been suggested that nigrostriatal dopaminergic transmission is modulated by nitric oxide (NO). Since there is evidence that gonadal hormones can affect extrapyramidal motor behavior in mammals, we investigated the effects of isosorbide dinitrate (ISD), linsidomine (SIN-1) and S-nitroso-N-acetylpenicillamine (SNAP), three pharmacologically different NO donors, on neuroleptic-induced catalepsy in 60- to 80-day-old male and female albino mice. Catalepsy was induced with haloperidol (1 mg/kg, ip) and measured at 30-min intervals by means of a bar test. Drugs (or appropriate vehicle) were injected ip 30 min before haloperidol, with each animal being used only once. ISD (5, 20 and 50 mg/kg) caused a dose-dependent inhibition of catalepsy in male mice (maximal effect 120 min after haloperidol: 64% inhibition). In the females only at the highest dose of ISD was an attenuation of catalepsy observed, which was mild and short lasting. SIN-1 (10 and 50 mg/kg) did not significantly affect catalepsy in female mice, while a significant attenuation was observed in males at the dose of 50 mg/kg (maximal inhibition: 60%). SNAP (20 mg/kg) significantly attenuated catalepsy in males 120 min after haloperidol (44% inhibition), but had no significant effect on females. These results basically agree with literature data showing that NO facilitates central dopaminergic transmission, although the mechanisms are not fully understood. They also reveal the existence of gender-related differences in this nitrergic modulation in mice, with females being less affected than males.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563527     DOI: 10.1590/s0100-879x2003000200012

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

1.  Effect of Tribulus terrestris on Haloperidol-induced Catalepsy in Mice.

Authors:  B S Nishchal; S Rai; M N Prabhu; Sheetal D Ullal; S Rajeswari; H N Gopalakrishna
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

2.  Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.

Authors:  A Mohajjel Nayebi A; H Sheidaei
Journal:  Daru       Date:  2010       Impact factor: 3.117

3.  Selective cyclooxygenase-2 inhibitor compound 11b improves haloperidol-induced catatonia by enhancing the striatum dopaminergic neurotransmission.

Authors:  Mohammad Reza Aghasadeghi; Seyyed Davar Siadat; Mehdi Shafiee Ardestani; Ali Jabbari Arabzadeh; Mitra Elmi; Hadi Fathi Moghaddam
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

4.  The selective cyclooxygenase-2 inhibitor, the compound 11b improves haloperidol induced catatonia by enhancing the striatum dopaminergic neurotransmission.

Authors:  Hadi Fathi-Moghaddam; Mehdi Shafiee Ardestani; Mostafa Saffari; Ali Jabbari Arabzadeh; Mitra Elmi
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.